225 related articles for article (PubMed ID: 38141214)
21. IARC use of oxidative stress as key mode of action characteristic for facilitating cancer classification: Glyphosate case example illustrating a lack of robustness in interpretative implementation.
Bus JS
Regul Toxicol Pharmacol; 2017 Jun; 86():157-166. PubMed ID: 28274811
[TBL] [Abstract][Full Text] [Related]
22. Development of a database on tumors and tumor sites in humans and in experimental animals for 'Group 1 agents identified through volume 109 of the
Grosse Y; Lajoie P; Billard M; Krewski D; Rice J; Baan RA; Cogliano V; Bird M; Zielinski JM
J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):237-243. PubMed ID: 31612803
[TBL] [Abstract][Full Text] [Related]
23. From hazard identification to weighing the benefits and drawbacks of prevention.
Vainio H; Weiderpass E
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):28-33. PubMed ID: 16005922
[TBL] [Abstract][Full Text] [Related]
24. Chemicals and industrial processes associated with cancer in humans. IARC Monographs, Volumes 1 to 20.
Althouse R; Huff J; Tomatis L; Wilbourn J
IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1979 Sep; (1):1-71. PubMed ID: 296141
[TBL] [Abstract][Full Text] [Related]
25. Application of the Key Characteristics of Carcinogens to Bisphenol A.
Ricker K; Cheng V; Hsieh CJ; Tsai FC; Osborne G; Li K; Yilmazer-Musa M; Sandy MS; Cogliano VJ; Schmitz R; Sun M
Int J Toxicol; 2024; 43(3):253-290. PubMed ID: 38204208
[TBL] [Abstract][Full Text] [Related]
26. IARC monographs: 40 years of evaluating carcinogenic hazards to humans.
Pearce N; Blair A; Vineis P; Ahrens W; Andersen A; Anto JM; Armstrong BK; Baccarelli AA; Beland FA; Berrington A; Bertazzi PA; Birnbaum LS; Brownson RC; Bucher JR; Cantor KP; Cardis E; Cherrie JW; Christiani DC; Cocco P; Coggon D; Comba P; Demers PA; Dement JM; Douwes J; Eisen EA; Engel LS; Fenske RA; Fleming LE; Fletcher T; Fontham E; Forastiere F; Frentzel-Beyme R; Fritschi L; Gerin M; Goldberg M; Grandjean P; Grimsrud TK; Gustavsson P; Haines A; Hartge P; Hansen J; Hauptmann M; Heederik D; Hemminki K; Hemon D; Hertz-Picciotto I; Hoppin JA; Huff J; Jarvholm B; Kang D; Karagas MR; Kjaerheim K; Kjuus H; Kogevinas M; Kriebel D; Kristensen P; Kromhout H; Laden F; Lebailly P; LeMasters G; Lubin JH; Lynch CF; Lynge E; 't Mannetje A; McMichael AJ; McLaughlin JR; Marrett L; Martuzzi M; Merchant JA; Merler E; Merletti F; Miller A; Mirer FE; Monson R; Nordby KC; Olshan AF; Parent ME; Perera FP; Perry MJ; Pesatori AC; Pirastu R; Porta M; Pukkala E; Rice C; Richardson DB; Ritter L; Ritz B; Ronckers CM; Rushton L; Rusiecki JA; Rusyn I; Samet JM; Sandler DP; de Sanjose S; Schernhammer E; Costantini AS; Seixas N; Shy C; Siemiatycki J; Silverman DT; Simonato L; Smith AH; Smith MT; Spinelli JJ; Spitz MR; Stallones L; Stayner LT; Steenland K; Stenzel M; Stewart BW; Stewart PA; Symanski E; Terracini B; Tolbert PE; Vainio H; Vena J; Vermeulen R; Victora CG; Ward EM; Weinberg CR; Weisenburger D; Wesseling C; Weiderpass E; Zahm SH
Environ Health Perspect; 2015 Jun; 123(6):507-14. PubMed ID: 25712798
[TBL] [Abstract][Full Text] [Related]
27. The contribution of molecular epidemiology to the identification of human carcinogens: current status and future perspectives.
Boffetta P; Islami F
Ann Oncol; 2013 Apr; 24(4):901-8. PubMed ID: 23136234
[TBL] [Abstract][Full Text] [Related]
28. Software Tools to Facilitate Systematic Review Used for Cancer Hazard Identification.
Shapiro AJ; Antoni S; Guyton KZ; Lunn RM; Loomis D; Rusyn I; Jahnke GD; Schwingl PJ; Mehta SS; Addington J; Guha N
Environ Health Perspect; 2018 Oct; 126(10):104501. PubMed ID: 30392397
[TBL] [Abstract][Full Text] [Related]
29. Mapping the key characteristics of carcinogens for glyphosate and its formulations: A systematic review.
Rana I; Nguyen PK; Rigutto G; Louie A; Lee J; Smith MT; Zhang L
Chemosphere; 2023 Oct; 339():139572. PubMed ID: 37474029
[TBL] [Abstract][Full Text] [Related]
30. Categorizing the characteristics of human carcinogens: a need for specificity.
Smith CJ; Perfetti TA; Hayes AW; Berry SC; Trosko JE; King JA; Goodman JI; Begley CG; Dayan A
Arch Toxicol; 2021 Aug; 95(8):2883-2889. PubMed ID: 34148101
[TBL] [Abstract][Full Text] [Related]
31. Use of mechanistic data in the IARC evaluations of the carcinogenicity of polychlorinated biphenyls and related compounds.
Lauby-Secretan B; Loomis D; Baan R; El Ghissassi F; Bouvard V; Benbrahim-Tallaa L; Guha N; Grosse Y; Straif K
Environ Sci Pollut Res Int; 2016 Feb; 23(3):2220-9. PubMed ID: 26077316
[TBL] [Abstract][Full Text] [Related]
32. Commentary: Role and communications of cancer hazard determinations.
Samet JM; Berrington de Gonzalez A; Lunn RM; Schubauer-Berigan MK
Carcinogenesis; 2022 Mar; 43(2):79-81. PubMed ID: 35016221
[TBL] [Abstract][Full Text] [Related]
33. Genetic toxicology data in the evaluation of potential human environmental carcinogens.
Waters MD; Stack HF; Jackson MA
Mutat Res; 1999 Jul; 437(1):21-49. PubMed ID: 10425388
[TBL] [Abstract][Full Text] [Related]
34. 1,3-Butadiene, isoprene and chloroprene: reviews by the IARC monographs programme, outstanding issues, and research priorities in epidemiology.
Rice JM; Boffetta P
Chem Biol Interact; 2001 Jun; 135-136():11-26. PubMed ID: 11397378
[TBL] [Abstract][Full Text] [Related]
35. Trichloroethylene: Mechanistic, epidemiologic and other supporting evidence of carcinogenic hazard.
Rusyn I; Chiu WA; Lash LH; Kromhout H; Hansen J; Guyton KZ
Pharmacol Ther; 2014 Jan; 141(1):55-68. PubMed ID: 23973663
[TBL] [Abstract][Full Text] [Related]
36. Use of carcinogenicity bioassays in the IARC monographs.
Cogliano VJ
Ann N Y Acad Sci; 2006 Sep; 1076():592-600. PubMed ID: 17119235
[TBL] [Abstract][Full Text] [Related]
37. False positives in cancer epidemiology.
McLaughlin JK; Tarone RE
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):11-5. PubMed ID: 23118145
[TBL] [Abstract][Full Text] [Related]
38. Screening assays for carcinogenic agents and mixtures: an appraisal based on data in the IARC Monograph series.
Bartsch H; Malaveille C
IARC Sci Publ; 1990; (104):65-74. PubMed ID: 2228144
[TBL] [Abstract][Full Text] [Related]
39. Application of the key characteristics of carcinogens in cancer hazard identification.
Guyton KZ; Rusyn I; Chiu WA; Corpet DE; van den Berg M; Ross MK; Christiani DC; Beland FA; Smith MT
Carcinogenesis; 2018 Apr; 39(4):614-622. PubMed ID: 29562322
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
